CSE PREV
LAST 0.73
CHANGE 0.03
OTC PRVCF
FSE 18H
CSE: PREV
LAST: 0.73
CHANGE: 0.03
OTC: PRVCF
FSE: 18H
Download as PDF  

Carrara Final Equity Raise

Please see attached the subscription agreement for our last equity raise prior to being publically listed. The raise is being done through Carrara Explorations Corp. (pubco), which is being acquired by us, and will close on the acquisition making the subscriber effectively a PreveCeutical Medical Inc. shareholder on closing. Each Unit consists of CA$0.50 a share with a full Warrant at CA$1.00 with a CA$1.50 Accelerator. Please note that you either have to be an accredited investor or friends and family to invest in Carrara Explorations Corp. (PreveCeutical Medical Inc.). If you are not friends or family or an accredited investor you may subscribe for shares through your registered broker, under the Broker's Suitability Exemption. Interest in the investment has been expressed greatly, therefore we can not guarantee that you will be able to participate in full.

On Behalf of the Board,

Stephen Van Deventer
Chairman & CEO
PreveCeutical Medical Inc.

For further information, please send an email to: info@preveceutical.com

Sign up for the latest news and updates